Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus

Gastrointestinal Endoscopy

Volumn 81, Issue 5, 2015, Pages 1158-1166.e4

  Small, Aaron J ^a   Sutherland, Scott E ^a   Hightower, Jessica S ^a   Guarner Argente, Carlos ^b   Furth, Emma E ^a   Kochman, Michael L ^a,c   Forde, Kimberly A ^a   Bewtra, Meenakshi ^a   Falk, Gary W ^a   Ginsberg, Gregory G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Wilmott Center for Endoscopic Innovation Research and Training Wilmott   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RECURRENCE; COHORT ANALYSIS; ENDOSCOPIC THERAPY; ERADICATION THERAPY; ESOPHAGUS CARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; HUMAN; INTRAMUCOSAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; ADENOCARCINOMA; CATHETER ABLATION; COMPARATIVE STUDY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CATHETER ABLATION; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 84927541937     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.10.029     Document Type: Article

References (26)

1. J.A. Abrams, D.L. Buono, and J. Strauss Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly Cancer 115 2009 4924 4933
2. C. Schieman, D.A. Wigle, and C. Deschamps Patterns of operative mortality following esophagectomy Dis Esophagus 25 2012 645 651
3. S. Rasool, B. A Ganai, and A. Syed Sameer Esophageal cancer: associated factors with special reference to the Kashmir Valley Tumori 98 2012 191 203
4. S.R. Kadri, P. Lao-Sirieix, and M. O'Donovan Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study BMJ 341 2010 c4372
5. S.J. Spechler, P. Sharma, and R.F. Souza American Gastroenterological Association medical position statement on the management of Barrett's esophagus Gastroenterology 140 2011 1084 1091
6. C. Bennett, N. Vakil, and J. Bergman Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process Gastroenterology 143 2012 336 346
7. S. Wani, D. Early, and S. Edmundowicz Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus Clin Gastroenterol Hepatol 10 2012 704 711
8. C. Guarner-Argente, T. Buoncristiano, and E.E. Furth Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication Gastrointest Endosc 77 2013 190 199
9. K.B. Dunbar, and S.J. Spechler The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review Am J Gastroenterol 107 2012 850 862
10. R.J. Badreddine, G.A. Prasad, and K.K. Wang Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus Gastrointest Endosc 71 2010 697 703
11. O. Pech, A. Behrens, and A. May Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus Gut 57 2008 1200 1206
12. E.S. Orman, H.P. Kim, and W.J. Bulsiewicz Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation Am J Gastroenterol 108 2013 187 195
13. G.G. Ginsberg Endoluminal therapy for Barrett's with high-grade dysplasia and early esophageal adenocarcinoma Clin Gastroenterol Hepatol 1 2003 241 245
14. K.N. Phoa, R.E. Pouw, and F.G. van Vilsteren Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study Gastroenterology 145 2013 96 104
15. N.J. Shaheen, B.F. Overholt, and R.E. Sampliner Durability of radiofrequency ablation in Barrett's esophagus with dysplasia Gastroenterology 141 2011 460 468
16. F.G. van Vilsteren, L. Alvarez Herrero, and R.E. Pouw Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study Endoscopy 45 2013 516 525
17. K. Krishnan, J.E. Pandolfino, and P.J. Kahrilas Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation Gastroenterology 143 2012 576 581
18. F.G. van Vilsteren, R.E. Pouw, and S. Seewald Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial Gut 60 2011 765 773
19. A.J. Small, C. Guarner-Argente, and G.W. Falk The impact of WIDE-AREA endoluminal resection on endoscopic therapy for Barrett's dysplasia and early carcinoma Gastrointest Endosc 77 2013 AB332
20. H.P. Kim, W.J. Bulsiewicz, and C.C. Cotton Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia Gastrointest Endosc 76 2012 733 739
21. S.J. Spechler, P. Sharma, and B. Traxler Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial Am J Gastroenterol 101 2006 1964 1971
22. B.J. Qumseya, A.M. Panossian, and C. Rizk Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection Dig Liver Dis 45 2013 1028 1033
23. P. Sharma, J. Dent, and D. Armstrong The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria Gastroenterology 131 2006 1392 1399
24. C. Guarner-Argente, T. Buoncristiano, and E.E. Furth Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication Gastrointest Endosc 77 2013 190 199
25. R.J. Badreddine, G.A. Prasad, and K.K. Wang Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus Gastrointest Endosc 71 2010 697 703
26. O. Pech, A. Behrens, and A. May Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus Gut 57 2008 1200 1206